[ad_1] Shares of Glenmark Pharmaceuticals Ltd. fell as much as 7% on Wednesday, April 9, after the US Food and Drug Administration (FDA) announced a Class-II recall of 39 drugs from the company’s US arm. The recall, initiated in March, was classified as Class-II by the FDA on April 8, 2025. Most of the recalled […]
Glenmark Pharmaceuticals secures US FDA approval for Olopatadine ophthalmic solution – CNBC TV18
[ad_1] Glenmark Pharmaceuticals Ltd on Thursday (March 20) said its arms Pharmaceuticals Inc., USA, has received final approval from the US Food & Drug Administration (USFDA) for its Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC). The product has been determined to be bioequivalent to Pataday Once Daily Relief Ophthalmic Solution, 0.2% (OTC), developed by Alcon […]
Stocks to Watch on February 17: BHEL, Samvardhana Motherson, RVNL, Glenmark Pharma and more – CNBC TV18
[ad_1] 1 / 14 BHEL | State-run engineering giant announced a significant contract win, securing an order worth ₹6,700 crore from Singareni Collieries Company (SCCL) to establish an 800 MW thermal power unit in Telangana. The contract, awarded on an Engineering, Procurement, and Construction (EPC) basis, covers the design, engineering, manufacturing, supply, erection, commissioning, and […]
Glenmark Pharma shares jump up to 4% on Phase 1 results for blood cancer drug – CNBC TV18
[ad_1] Shares of Glenmark Pharma Ltd. gained up to 4% on Tuesday, December 10, following first clinical data from the Phase 1 studi of a cancer treating drug. Company Value Change %Change Glenmark in an exchange filing said that the first clinical data from Phase 1 study of Trispecific TREAT Antibody, ISB 2001, showed a […]
Glenmark Pharma Q2 Results | Drug firm returns to profit, revenue up 7% – CNBC TV18
[ad_1] Drug firm Glenmark Pharmaceuticals Ltd on Thursday (November 14) reported a net profit of ₹354.4 crore for the second quarter that ended September 30, 2024. In the corresponding quarter of the previous fiscal, Glenmark Pharmaceuticals posted a net loss of ₹180.2 crore, the company said in a regulatory filing. Revenue from operations increased 7.1% […]
Glenmark Pharmaceuticals Q1 net profit zooms to ₹340 crore, revenue up 7% – CNBC TV18
[ad_1] Drug firm Glenmark Pharmaceuticals Ltd on Wednesday (August 14) reported over two-fold increase in consolidated net profit to ₹340.2 crore for the first quarter that ended June 30, 2024. In the corresponding quarter, Glenmark Pharmaceuticals posted a net profit of ₹37.7 crore, the company said in a regulatory filing. The company reported consolidated profit […]
Analysts see upside in LIC Housing Finance, Glenmark Pharma and Infosys – CNBC TV18
[ad_1] SUMMARY On Tuesday, market tech analyst Mitessh Thakkar and F&O analyst Avani Bhatt recommended these stocks for the short term. By CNBCTV18.com August 13, 2024, 9:37:10 AM IST (Published) 1 / 10 Technical analyst Mitessh Thakkar of earningwaves.com along with Futures and Options analyst Avani Bhatt, Senior VP, Equity Derivative Research at JM Financial Services […]